- Home
- OZKAP vs BBIO Comparison
OZKAP vs BBIO Comparison
Compare OZKAP & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OZKAP
- BBIO
- Stock Information
- Founded
- OZKAP N/A
- BBIO 2015
- Country
- OZKAP United States
- BBIO United States
- Employees
- OZKAP 3028
- BBIO N/A
- Industry
- OZKAP Major Banks
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- OZKAP Finance
- BBIO Health Care
- Exchange
- OZKAP Nasdaq
- BBIO Nasdaq
- Market Cap
- OZKAP N/A
- BBIO 6.7B
- IPO Year
- OZKAP N/A
- BBIO 2019
- Fundamental
- Price
- OZKAP $16.79
- BBIO $35.68
- Analyst Decision
- OZKAP
- BBIO Strong Buy
- Analyst Count
- OZKAP 0
- BBIO 12
- Target Price
- OZKAP N/A
- BBIO $57.09
- AVG Volume (30 Days)
- OZKAP N/A
- BBIO 3.1M
- Earning Date
- OZKAP N/A
- BBIO 04-29-2025
- Dividend Yield
- OZKAP N/A
- BBIO N/A
- EPS Growth
- OZKAP N/A
- BBIO N/A
- EPS
- OZKAP N/A
- BBIO N/A
- Revenue
- OZKAP N/A
- BBIO $127,415,000.00
- Revenue This Year
- OZKAP N/A
- BBIO $13.67
- Revenue Next Year
- OZKAP N/A
- BBIO $118.02
- P/E Ratio
- OZKAP N/A
- BBIO N/A
- Revenue Growth
- OZKAP N/A
- BBIO N/A
- 52 Week Low
- OZKAP N/A
- BBIO $21.62
- 52 Week High
- OZKAP N/A
- BBIO $39.47
- Technical
- Relative Strength Index (RSI)
- OZKAP 53.71
- BBIO 51.21
- Support Level
- OZKAP $16.45
- BBIO $33.92
- Resistance Level
- OZKAP $16.92
- BBIO $39.16
- Average True Range (ATR)
- OZKAP 0.32
- BBIO 1.56
- MACD
- OZKAP 0.02
- BBIO -0.24
- Stochastic Oscillator
- OZKAP 56.57
- BBIO 31.32
About OZKAP Bank OZK 4.625% Series A Non-Cumulative Perpetual Preferred Stock
Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides a range of banking services which include deposit services such as checking, savings, money market, time deposit, and individual retirement accounts to loan services like real estate, consumer, commercial, and industrial loans. Apart from providing traditional banking products and services it also provides treasury management, trust and wealth management, financial planning, online banking, and other related services.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.